University of Liverpool-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

2022

  1. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries

    PLoS ONE, Vol. 17, Núm. 6 6

2015

  1. Differences in cancer drug assessment between Spain and the United Kingdom

    European Journal of Cancer, Vol. 51, Núm. 13, pp. 1843-1852

2011

  1. The passive transfer of immunoglobulin G serum antibodies from patients with longstanding Complex Regional Pain Syndrome

    European Journal of Pain, Vol. 15, Núm. 5, pp. 504.e1-504.e6

1999

  1. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study

    Lancet, Vol. 354, Núm. 9172, pp. 13-19